262 related articles for article (PubMed ID: 15840669)
21. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms.
Wolf G
Nephrologie; 1998; 19(7):451-6. PubMed ID: 9857383
[TBL] [Abstract][Full Text] [Related]
22. Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts.
Kobayashi T; Liu X; Wen FQ; Fang Q; Abe S; Wang XQ; Hashimoto M; Shen L; Kawasaki S; Kim HJ; Kohyama T; Rennard SI
Biochem Biophys Res Commun; 2005 Feb; 327(2):393-8. PubMed ID: 15629128
[TBL] [Abstract][Full Text] [Related]
23. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
Krag S; Nyengaard JR; Wogensen L
Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404
[TBL] [Abstract][Full Text] [Related]
24. Effects of new peritoneal dialysis solutions, pyridoxamine and AT1 receptor blocker, on TGF-beta1 and VEGF expression in rat peritoneal mesothelial cells.
Mizuiri S; Ohashi Y; Hemmi H; Arita M; Yamada K; Aoki T; Miyagi M; Sakai K; Aikawa A
Am J Nephrol; 2009; 30(3):295-302. PubMed ID: 19546527
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
26. Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.
Xiao HQ; Shi W; Liu SX; Zhang B; Xu LX; Liang XL; Liang YZ
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):682-9. PubMed ID: 19594554
[TBL] [Abstract][Full Text] [Related]
27. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
28. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.
Ziyadeh FN
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S38-41. PubMed ID: 18842317
[TBL] [Abstract][Full Text] [Related]
29. TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes.
Wu DT; Bitzer M; Ju W; Mundel P; Böttinger EP
J Am Soc Nephrol; 2005 Nov; 16(11):3211-21. PubMed ID: 16207831
[TBL] [Abstract][Full Text] [Related]
30. Can TGF-beta1 and rhBMP-2 act in synergy to transform bone marrow stem cells to discogenic-type cells?
Kuh SU; Zhu Y; Li J; Tsai KJ; Fei Q; Hutton WC; Yoon ST
Acta Neurochir (Wien); 2008 Oct; 150(10):1073-9; discussion 1079. PubMed ID: 18781274
[TBL] [Abstract][Full Text] [Related]
31. [The effect of tubular epithelial cells activated by aldosterone on renal interstitial fibroblasts in co-culture system].
Luo Y; Chen YP
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2070-5. PubMed ID: 16313806
[TBL] [Abstract][Full Text] [Related]
32. Effect of vasopressin on type IV collagen production in human mesangial cells.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Regul Pept; 2008 Apr; 147(1-3):60-6. PubMed ID: 18258315
[TBL] [Abstract][Full Text] [Related]
33. The Notch pathway mediates the angiotensin II-induced synthesis of extracellular matrix components in podocytes.
Yao M; Wang X; Wang X; Zhang T; Chi Y; Gao F
Int J Mol Med; 2015 Jul; 36(1):294-300. PubMed ID: 25902289
[TBL] [Abstract][Full Text] [Related]
34. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.
Baba M; Wada J; Eguchi J; Hashimoto I; Okada T; Yasuhara A; Shikata K; Kanwar YS; Makino H
J Am Soc Nephrol; 2005 Nov; 16(11):3222-34. PubMed ID: 16177004
[TBL] [Abstract][Full Text] [Related]
35. Roxithromycin inhibits transforming growth factor-beta production by cultured human mesangial cells.
Yamabe H; Shimada M; Kaizuka M; Nakamura M; Kumasaka R; Murakami R; Fujita T; Nakamura N; Osawa H; Okumura K
Nephrology (Carlton); 2006 Dec; 11(6):524-30. PubMed ID: 17199791
[TBL] [Abstract][Full Text] [Related]
36. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
37. The bioactivity of transforming growth factor-beta1 can be regulated via binding to dermal collagens in mink lung epithelial cells.
Shibuya H; Okamoto O; Fujiwara S
J Dermatol Sci; 2006 Mar; 41(3):187-95. PubMed ID: 16337361
[TBL] [Abstract][Full Text] [Related]
38. Tendon healing in vitro: modification of tenocytes with exogenous vascular endothelial growth factor gene increases expression of transforming growth factor beta but minimally affects expression of collagen genes.
Wang XT; Liu PY; Tang JB
J Hand Surg Am; 2005 Mar; 30(2):222-9. PubMed ID: 15781343
[TBL] [Abstract][Full Text] [Related]
39. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
40. Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF.
Leung JC; Chan LY; Li FF; Tang SC; Chan KW; Chan TM; Lam MF; Wieslander A; Lai KN
Nephrol Dial Transplant; 2005 Jul; 20(7):1336-49. PubMed ID: 15814533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]